TargetSerine/threonine-protein kinase ATR(Homo sapiens (Human))
Wuxi Biocity Biopharmaceutics
US Patent
Wuxi Biocity Biopharmaceutics
US Patent
Affinity DataIC50: 12nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase ATR(Homo sapiens (Human))
Wuxi Biocity Biopharmaceutics
US Patent
Wuxi Biocity Biopharmaceutics
US Patent
Affinity DataIC50: 14nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase ATR(Homo sapiens (Human))
Wuxi Biocity Biopharmaceutics
US Patent
Wuxi Biocity Biopharmaceutics
US Patent
Affinity DataIC50: 15nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase ATR(Homo sapiens (Human))
Wuxi Biocity Biopharmaceutics
US Patent
Wuxi Biocity Biopharmaceutics
US Patent
Affinity DataIC50: 16nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase ATR(Homo sapiens (Human))
Wuxi Biocity Biopharmaceutics
US Patent
Wuxi Biocity Biopharmaceutics
US Patent
Affinity DataIC50: 18nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase ATR(Homo sapiens (Human))
Wuxi Biocity Biopharmaceutics
US Patent
Wuxi Biocity Biopharmaceutics
US Patent
Affinity DataIC50: 19nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase ATR(Homo sapiens (Human))
Wuxi Biocity Biopharmaceutics
US Patent
Wuxi Biocity Biopharmaceutics
US Patent
Affinity DataIC50: 20nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase ATR(Homo sapiens (Human))
Wuxi Biocity Biopharmaceutics
US Patent
Wuxi Biocity Biopharmaceutics
US Patent
Affinity DataIC50: 20nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase ATR(Homo sapiens (Human))
Wuxi Biocity Biopharmaceutics
US Patent
Wuxi Biocity Biopharmaceutics
US Patent
Affinity DataIC50: 24nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase ATR(Homo sapiens (Human))
Wuxi Biocity Biopharmaceutics
US Patent
Wuxi Biocity Biopharmaceutics
US Patent
Affinity DataIC50: 26nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase ATR(Homo sapiens (Human))
Wuxi Biocity Biopharmaceutics
US Patent
Wuxi Biocity Biopharmaceutics
US Patent
Affinity DataIC50: 27nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase ATR(Homo sapiens (Human))
Wuxi Biocity Biopharmaceutics
US Patent
Wuxi Biocity Biopharmaceutics
US Patent
Affinity DataIC50: 27nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase ATR(Homo sapiens (Human))
Wuxi Biocity Biopharmaceutics
US Patent
Wuxi Biocity Biopharmaceutics
US Patent
Affinity DataIC50: 28nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase ATR(Homo sapiens (Human))
Wuxi Biocity Biopharmaceutics
US Patent
Wuxi Biocity Biopharmaceutics
US Patent
Affinity DataIC50: 29nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase ATR(Homo sapiens (Human))
Wuxi Biocity Biopharmaceutics
US Patent
Wuxi Biocity Biopharmaceutics
US Patent
Affinity DataIC50: 31nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase ATR(Homo sapiens (Human))
Wuxi Biocity Biopharmaceutics
US Patent
Wuxi Biocity Biopharmaceutics
US Patent
Affinity DataIC50: 32nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase ATR(Homo sapiens (Human))
Wuxi Biocity Biopharmaceutics
US Patent
Wuxi Biocity Biopharmaceutics
US Patent
Affinity DataIC50: 35nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase ATR(Homo sapiens (Human))
Wuxi Biocity Biopharmaceutics
US Patent
Wuxi Biocity Biopharmaceutics
US Patent
Affinity DataIC50: 35nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase ATR(Homo sapiens (Human))
Wuxi Biocity Biopharmaceutics
US Patent
Wuxi Biocity Biopharmaceutics
US Patent
Affinity DataIC50: 39nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase ATR(Homo sapiens (Human))
Wuxi Biocity Biopharmaceutics
US Patent
Wuxi Biocity Biopharmaceutics
US Patent
Affinity DataIC50: 41nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase ATR(Homo sapiens (Human))
Wuxi Biocity Biopharmaceutics
US Patent
Wuxi Biocity Biopharmaceutics
US Patent
Affinity DataIC50: 42nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase ATR(Homo sapiens (Human))
Wuxi Biocity Biopharmaceutics
US Patent
Wuxi Biocity Biopharmaceutics
US Patent
Affinity DataIC50: 42nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase ATR(Homo sapiens (Human))
Wuxi Biocity Biopharmaceutics
US Patent
Wuxi Biocity Biopharmaceutics
US Patent
Affinity DataIC50: 46nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase ATR(Homo sapiens (Human))
Wuxi Biocity Biopharmaceutics
US Patent
Wuxi Biocity Biopharmaceutics
US Patent
Affinity DataIC50: 47nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase ATR(Homo sapiens (Human))
Wuxi Biocity Biopharmaceutics
US Patent
Wuxi Biocity Biopharmaceutics
US Patent
Affinity DataIC50: 50nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase ATR(Homo sapiens (Human))
Wuxi Biocity Biopharmaceutics
US Patent
Wuxi Biocity Biopharmaceutics
US Patent
Affinity DataIC50: 53nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase ATR(Homo sapiens (Human))
Wuxi Biocity Biopharmaceutics
US Patent
Wuxi Biocity Biopharmaceutics
US Patent
Affinity DataIC50: 64nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase ATR(Homo sapiens (Human))
Wuxi Biocity Biopharmaceutics
US Patent
Wuxi Biocity Biopharmaceutics
US Patent
Affinity DataIC50: 65nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase ATR(Homo sapiens (Human))
Wuxi Biocity Biopharmaceutics
US Patent
Wuxi Biocity Biopharmaceutics
US Patent
Affinity DataIC50: 65nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase ATR(Homo sapiens (Human))
Wuxi Biocity Biopharmaceutics
US Patent
Wuxi Biocity Biopharmaceutics
US Patent
Affinity DataIC50: 65nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase ATR(Homo sapiens (Human))
Wuxi Biocity Biopharmaceutics
US Patent
Wuxi Biocity Biopharmaceutics
US Patent
Affinity DataIC50: 69nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase ATR(Homo sapiens (Human))
Wuxi Biocity Biopharmaceutics
US Patent
Wuxi Biocity Biopharmaceutics
US Patent
Affinity DataIC50: 69nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase ATR(Homo sapiens (Human))
Wuxi Biocity Biopharmaceutics
US Patent
Wuxi Biocity Biopharmaceutics
US Patent
Affinity DataIC50: 69nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase ATR(Homo sapiens (Human))
Wuxi Biocity Biopharmaceutics
US Patent
Wuxi Biocity Biopharmaceutics
US Patent
Affinity DataIC50: 72nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase ATR(Homo sapiens (Human))
Wuxi Biocity Biopharmaceutics
US Patent
Wuxi Biocity Biopharmaceutics
US Patent
Affinity DataIC50: 72nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase ATR(Homo sapiens (Human))
Wuxi Biocity Biopharmaceutics
US Patent
Wuxi Biocity Biopharmaceutics
US Patent
Affinity DataIC50: 75nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase ATR(Homo sapiens (Human))
Wuxi Biocity Biopharmaceutics
US Patent
Wuxi Biocity Biopharmaceutics
US Patent
Affinity DataIC50: 78nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase ATR(Homo sapiens (Human))
Wuxi Biocity Biopharmaceutics
US Patent
Wuxi Biocity Biopharmaceutics
US Patent
Affinity DataIC50: 78nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase ATR(Homo sapiens (Human))
Wuxi Biocity Biopharmaceutics
US Patent
Wuxi Biocity Biopharmaceutics
US Patent
Affinity DataIC50: 80nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase ATR(Homo sapiens (Human))
Wuxi Biocity Biopharmaceutics
US Patent
Wuxi Biocity Biopharmaceutics
US Patent
Affinity DataIC50: 81nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase ATR(Homo sapiens (Human))
Wuxi Biocity Biopharmaceutics
US Patent
Wuxi Biocity Biopharmaceutics
US Patent
Affinity DataIC50: 83nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase ATR(Homo sapiens (Human))
Wuxi Biocity Biopharmaceutics
US Patent
Wuxi Biocity Biopharmaceutics
US Patent
Affinity DataIC50: 83nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase ATR(Homo sapiens (Human))
Wuxi Biocity Biopharmaceutics
US Patent
Wuxi Biocity Biopharmaceutics
US Patent
Affinity DataIC50: 91nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase ATR(Homo sapiens (Human))
Wuxi Biocity Biopharmaceutics
US Patent
Wuxi Biocity Biopharmaceutics
US Patent
Affinity DataIC50: 92nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase ATR(Homo sapiens (Human))
Wuxi Biocity Biopharmaceutics
US Patent
Wuxi Biocity Biopharmaceutics
US Patent
Affinity DataIC50: 96nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase ATR(Homo sapiens (Human))
Wuxi Biocity Biopharmaceutics
US Patent
Wuxi Biocity Biopharmaceutics
US Patent
Affinity DataIC50: 97nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase ATR(Homo sapiens (Human))
Wuxi Biocity Biopharmaceutics
US Patent
Wuxi Biocity Biopharmaceutics
US Patent
Affinity DataIC50: 105nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase ATR(Homo sapiens (Human))
Wuxi Biocity Biopharmaceutics
US Patent
Wuxi Biocity Biopharmaceutics
US Patent
Affinity DataIC50: 115nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase ATR(Homo sapiens (Human))
Wuxi Biocity Biopharmaceutics
US Patent
Wuxi Biocity Biopharmaceutics
US Patent
Affinity DataIC50: 119nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase ATR(Homo sapiens (Human))
Wuxi Biocity Biopharmaceutics
US Patent
Wuxi Biocity Biopharmaceutics
US Patent
Affinity DataIC50: 123nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair